Transcriptional and Epigenetic Substrates of Methamphetamine Addiction and Withdrawal: Evidence from a Long-Access Self-Administration Model in the Rat

Molecular Neurobiology

Volumn 51, Issue 2, 2015, Pages 696-717

  Cadet, Jean Lud ^a   Brannock, Christie ^a   Jayanthi, Subramaniam ^a   Krasnova, Irina N ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cognition; Epigenetics; Gene expression; Gene networks; HDAC; Repressor complexes; Striatum; Transcription factors

Indexed keywords

METHAMPHETAMINE; TRANSCRIPTION FACTOR;

ADDICTION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; DRUG SELF ADMINISTRATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; HUMAN; RAT; TIME FACTOR;

ANIMALS; BEHAVIOR, ADDICTIVE; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; GENE REGULATORY NETWORKS; HUMANS; METHAMPHETAMINE; RATS; SELF ADMINISTRATION; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84935825520     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8776-8     Document Type: Review

References (214)

1. Cadet JL, Bisagno V, Milroy CM (2014) Neuropathology of substance use disorders. Acta Neuropathol 127(1):91–107. doi:10.1007/s00401-013-1221-7
2. Gonzales R, Mooney L, Rawson RA (2010) The methamphetamine problem in the United States. Annu Rev Public Health 31:385–398. doi:10.1146/annurev.publhealth.012809.103600
3. Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60(2):379–407. doi:10.1016/j.brainresrev.2009.03.002
4. Rusyniak DE (2013) Neurologic manifestations of chronic methamphetamine abuse. Psychiatr Clin N Am 36(2):261–275. doi:10.1016/j.psc.2013.02.005
5. Dean AC, Groman SM, Morales AM, London ED (2013) An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology 38(2):259–274. doi:10.1038/npp.2012.179
6. Henry BL, Minassian A, Perry W (2010) Effect of methamphetamine dependence on everyday functional ability. Addict Behav 35(6):593–598. doi:10.1016/j.addbeh.2010.01.013
7. Sadek JR, Vigil O, Grant I, Heaton RK (2007) The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol 29(3):266–276. doi:10.1080/13803390600659384
8. Brecht ML, von Mayrhauser C, Anglin MD (2000) Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs 32(2):211–220
9. Brecht ML, Greenwell L, von Mayrhauser C, Anglin MD (2006) Two-year outcomes of treatment for methamphetamine use. J Psychoactive Drugs Suppl 3:415–426
10. Cadet JL, Bisagno V (2013) The primacy of cognition in the manifestations of substance use disorders. Front Neurol 4:189. doi:10.3389/fneur.2013.00189
11. Krasnova IN, Chiflikyan M, Justinova Z, McCoy MT, Ladenheim B, Jayanthi S, Quintero C, Brannock C, Barnes C, Adair JE, Lehrmann E, Kobeissy FH, Gold MS, Becker KG, Goldberg SR, Cadet JL (2013) CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat. Neurobiol Dis 58:132–143. doi:10.1016/j.nbd.2013.05.009
12. Aguilar-Valles A, Vaissiere T, Griggs EM, Mikaelsson MA, Takacs IF, Young EJ, Rumbaugh G, Miller CA (2013) Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation. Biol Psychiatry. doi:10.1016/j.biopsych.2013.09.014
13. Cornish JL, Hunt GE, Robins L, McGregor IS (2012) Regional c-Fos and FosB/DeltaFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience 206:100–114. doi:10.1016/j.neuroscience.2012.01.004
14. Martin TA, Jayanthi S, McCoy MT, Brannock C, Ladenheim B, Garrett T, Lehrmann E, Becker KG, Cadet JL (2012) Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation/hypoacetylation in the rat nucleus accumbens. PLoS One 7(3):e34236. doi:10.1371/journal.pone.0034236
15. Jayanthi S, McCoy MT, Chen B, Britt JP, Kourrich S, Yau HJ, Ladenheim B, Krasnova IN, Bonci A, Cadet JL (2013) Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms. Biol Psychiatry. doi:10.1016/j.biopsych.2013.09.034
16. Belin D, Everitt BJ (2008) Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 57(3):432–441. doi:10.1016/j.neuron.2007.12.019
17. Nestler EJ (2012) Transcriptional mechanisms of drug addiction. Clin Psychopharmacol Neurosci 10(3):136–143. doi:10.9758/cpn.2012.10.3.136
18. Nestler EJ (2014) Epigenetic mechanisms of drug addiction. Neuropharmacology 76(Pt B):259–268. doi:10.1016/j.neuropharm.2013.04.004
19. Cadet JL, McCoy MT, Cai NS, Krasnova IN, Ladenheim B, Beauvais G, Wilson N, Wood W, Becker KG, Hodges AB (2009) Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum. PLoS One 4(11):e7812. doi:10.1371/journal.pone.0007812
20. Kodama M, Akiyama K, Ujike H, Shimizu Y, Tanaka Y, Kuroda S (1998) A robust increase in expression of arc gene, an effector immediate early gene, in the rat brain after acute and chronic methamphetamine administration. Brain Res 796(1–2):273–283
21. Krasnova IN, Ladenheim B, Hodges AB, Volkow ND, Cadet JL (2011) Chronic methamphetamine administration causes differential regulation of transcription factors in the rat midbrain. PLoS One 6(4):e19179. doi:10.1371/journal.pone.0019179
22. McCoy MT, Jayanthi S, Wulu JA, Beauvais G, Ladenheim B, Martin TA, Krasnova IN, Hodges AB, Cadet JL (2011) Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection. Psychopharmacology (Berl) 215(2):353–365. doi:10.1007/s00213-010-2146-7
23. Wang JQ, Smith AJ, McGinty JF (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience 68(1):83–95
24. Krasnova IN, Justinova Z, Ladenheim B, Jayanthi S, McCoy MT, Barnes C, Warner JE, Goldberg SR, Cadet JL (2010) Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS One 5(1):e8790. doi:10.1371/journal.pone.0008790
25. Smith KS, Graybiel AM (2013) A dual operator view of habitual behavior reflecting cortical and striatal dynamics. Neuron 79(2):361–374. doi:10.1016/j.neuron.2013.05.038
26. Yin HH, Knowlton BJ (2006) The role of the basal ganglia in habit formation. Nat Rev Neurosci 7(6):464–476. doi:10.1038/nrn1919
27. Graybiel AM (2008) Habits, rituals, and the evaluative brain. Annu Rev Neurosci 31:359–387. doi:10.1146/annurev.neuro.29.051605.112851
28. Feng J, Wilkinson M, Liu X, Purushothaman I, Ferguson D, Vialou V, Maze I, Shao N, Kennedy P, Koo J, Dias C, Laitman B, Stockman V, Laplant Q, Cahill M, Nestler EJ, Shen L (2014) Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens. Genome Biol 15(4):R65. doi:10.1186/gb-2014-15-4-r65
29. Ferguson D, Koo JW, Feng J, Heller E, Rabkin J, Heshmati M, Renthal W, Neve R, Liu X, Shao N, Sartorelli V, Shen L, Nestler EJ (2013) Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action. J Neurosci 33(41):16088–16098. doi:10.1523/JNEUROSCI.1284-13.2013
30. McFadden LM, Hadlock GC, Allen SC, Vieira-Brock PL, Stout KA, Ellis JD, Hoonakker AJ, Andrenyak DM, Nielsen SM, Wilkins DG, Hanson GR, Fleckenstein AE (2012) Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. J Pharmacol Exp Ther 340(2):295–303. doi:10.1124/jpet.111.188433
31. Schwendt M, Rocha A, See RE, Pacchioni AM, McGinty JF, Kalivas PW (2009) Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 331(2):555–562. doi:10.1124/jpet.109.155770
32. Schwendt M, Reichel CM, See RE (2012) Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats. PLoS One 7(3):e34299. doi:10.1371/journal.pone.0034299
33. McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2014) Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor. Int J Neuropsychopharmacol:1–6. doi:10.1017/S1461145714000327
34. Recinto P, Samant AR, Chavez G, Kim A, Yuan CJ, Soleiman M, Grant Y, Edwards S, Wee S, Koob GF, George O, Mandyam CD (2012) Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration. Neuropsychopharmacology 37(5):1275–1287. doi:10.1038/npp.2011.315
35. Reichel CM, Ramsey LA, Schwendt M, McGinty JF, See RE (2012) Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 62(2):1119–1126. doi:10.1016/j.neuropharm.2011.11.003
36. Rogers JL, De Santis S, See RE (2008) Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology (Berl) 199(4):615–624. doi:10.1007/s00213-008-1187-7
37. Parsegian A, Glen WB Jr, Lavin A, See RE (2011) Methamphetamine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol Psychiatry 69(3):253–259. doi:10.1016/j.biopsych.2010.09.003
38. Jang CG, Whitfield T, Schulteis G, Koob GF, Wee S (2013) A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats. Psychopharmacology (Berl) 225(3):753–763. doi:10.1007/s00213-012-2864-0
39. Kitamura O, Wee S, Specio SE, Koob GF, Pulvirenti L (2006) Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl) 186(1):48–53. doi:10.1007/s00213-006-0353-z
40. Cadet JL, Jayanthi S, McCoy MT, Ladenheim B, Saint-Preux F, Lehrmann E, De S, Becker KG, Brannock C (2013) Genome-wide profiling identifies a subset of methamphetamine (METH)-induced genes associated with METH-induced increased H4K5Ac binding in the rat striatum. BMC Genomics 14:545. doi:10.1186/1471-2164-14-545
41. Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, Carlo G, Bevins RA (2012) Methamphetamine-associated psychosis. J Neuroimmune Pharmacol 7(1):113–139. doi:10.1007/s11481-011-9288-1
42. Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED (2014) Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2014.399
43. Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Ueki T, Mori N, Gold MS, Cadet JL (2008) Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28(22):5756–5761. doi:10.1523/JNEUROSCI.1179-08.2008
44. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158(3):377–382
45. Maekawa S, Maekawa M, Hattori S, Nakamura S (1993) Purification and molecular cloning of a novel acidic calmodulin binding protein from rat brain. J Biol Chem 268(18):13703–13709
46. Mosevitsky MI (2005) Nerve ending "signal" proteins GAP-43, MARCKS, and BASP1. Int Rev Cytol 245:245–325. doi:10.1016/S0074-7696(05)45007-X
47. Shaw JE, Epand RF, Sinnathamby K, Li Z, Bittman R, Epand RM, Yip CM (2006) Tracking peptide-membrane interactions: insights from in situ coupled confocal-atomic force microscopy imaging of NAP-22 peptide insertion and assembly. J Struct Biol 155(3):458–469. doi:10.1016/j.jsb.2006.04.015
48. Frey D, Laux T, Xu L, Schneider C, Caroni P (2000) Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol 149(7):1443–1454
49. Korshunova I, Caroni P, Kolkova K, Berezin V, Bock E, Walmod PS (2008) Characterization of BASP1-mediated neurite outgrowth. J Neurosci Res 86(10):2201–2213. doi:10.1002/jnr.21678
50. Carpenter B, Hill KJ, Charalambous M, Wagner KJ, Lahiri D, James DI, Andersen JS, Schumacher V, Royer-Pokora B, Mann M, Ward A, Roberts SG (2004) BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol Cell Biol 24(2):537–549
51. Goodfellow SJ, Rebello MR, Toska E, Zeef LA, Rudd SG, Medler KF, Roberts SG (2011) WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line. Biochem J 435(1):113–125. doi:10.1042/BJ20101734
52. Green LM, Wagner KJ, Campbell HA, Addison K, Roberts SG (2009) Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation. Nucleic Acids Res 37(2):431–440. doi:10.1093/nar/gkn955
53. Toska E, Campbell HA, Shandilya J, Goodfellow SJ, Shore P, Medler KF, Roberts SG (2012) Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. Cell Rep 2(3):462–469. doi:10.1016/j.celrep.2012.08.005
54. Hollenhorst PC, McIntosh LP, Graves BJ (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80:437–471. doi:10.1146/annurev.biochem.79.081507.103945
55. Sharrocks AD (1995) ERK2/p42 MAP kinase stimulates both autonomous and SRF-dependent DNA binding by Elk-1. FEBS Lett 368(1):77–80
56. Yang SH, Whitmarsh AJ, Davis RJ, Sharrocks AD (1998) Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. Embo J 17(6):1740–1749. doi:10.1093/emboj/17.6.1740
57. Cahill E, Salery M, Vanhoutte P, Caboche J (2014) Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. Front Pharmacol 4:172. doi:10.3389/fphar.2013.00172
58. Valjent E, Corvol JC, Pages C, Besson MJ, Maldonado R, Caboche J (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 20(23):8701–8709
59. Valjent E, Pages C, Herve D, Girault JA, Caboche J (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19(7):1826–1836. doi:10.1111/j.1460-9568.2004.03278.x
60. Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, Stipanovich A, Caboche J, Lombroso PJ, Nairn AC, Greengard P, Herve D, Girault JA (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 102(2):491–496. doi:10.1073/pnas.0408305102
61. Zheng CF, Guan KL (1993) Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J Biol Chem 268(32):23933–23939
62. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65(4):663–675
63. Sgambato V, Vanhoutte P, Pages C, Rogard M, Hipskind R, Besson MJ, Caboche J (1998) In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J Neurosci 18(1):214–226
64. Odrowaz Z, Sharrocks AD (2012) ELK1 uses different DNA binding modes to regulate functionally distinct classes of target genes. PLoS Genet 8(5):e1002694. doi:10.1371/journal.pgen.1002694
65. Boros J, Donaldson IJ, O'Donnell A, Odrowaz ZA, Zeef L, Lupien M, Meyer CA, Liu XS, Brown M, Sharrocks AD (2009) Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 19(11):1963–1973. doi:10.1101/gr.093047.109
66. O'Donnell A, Odrowaz Z, Sharrocks AD (2012) Immediate-early gene activation by the MAPK pathways: what do and don’t we know? Biochem Soc Trans 40(1):58–66. doi:10.1042/BST20110636
67. Sgambato V, Pages C, Rogard M, Besson MJ, Caboche J (1998) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J Neurosci 18(21):8814–8825
68. Mao LM, Reusch JM, Fibuch EE, Liu Z, Wang JQ (2013) Amphetamine increases phosphorylation of MAPK/ERK at synaptic sites in the rat striatum and medial prefrontal cortex. Brain Res 1494:101–108. doi:10.1016/j.brainres.2012.11.038
69. Salzmann J, Marie-Claire C, Le Guen S, Roques BP, Noble F (2003) Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br J Pharmacol 140(5):831–838. doi:10.1038/sj.bjp.0705506
70. Zhao N, Chen Y, Zhu J, Wang L, Cao G, Dang Y, Yan C, Wang J, Chen T (2014) Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice. Neuroscience 258:101–110. doi:10.1016/j.neuroscience.2013.11.025
71. Besnard A, Bouveyron N, Kappes V, Pascoli V, Pages C, Heck N, Vanhoutte P, Caboche J (2011) Alterations of molecular and behavioral responses to cocaine by selective inhibition of Elk-1 phosphorylation. J Neurosci 31(40):14296–14307. doi:10.1523/JNEUROSCI.2890-11.2011
72. Adams JP, Sweatt JD (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135–163. doi:10.1146/annurev.pharmtox.42.082701.145401
73. Johannessen M, Moens U (2007) Multisite phosphorylation of the cAMP response element-binding protein (CREB) by a diversity of protein kinases. Front Biosci 12:1814–1832
74. Davis S, Vanhoutte P, Pages C, Caboche J, Laroche S (2000) The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J Neurosci 20(12):4563–4572
75. Choe ES, McGinty JF (2001) Cyclic AMP and mitogen-activated protein kinases are required for glutamate-dependent cyclic AMP response element binding protein and Elk-1 phosphorylation in the dorsal striatum in vivo. J Neurochem 76(2):401–412
76. Matamales M, Girault JA (2011) Signaling from the cytoplasm to the nucleus in striatal medium-sized spiny neurons. Front Neuroanat 5:37. doi:10.3389/fnana.2011.00037
77. Shaywitz AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821–861. doi:10.1146/annurev.biochem.68.1.821
78. Janknecht R (2002) The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. Histol Histopathol 17(2):657–668
79. Barco A, Patterson SL, Alarcon JM, Gromova P, Mata-Roig M, Morozov A, Kandel ER (2005) Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Neuron 48(1):123–137. doi:10.1016/j.neuron.2005.09.005
80. Beaumont TL, Yao B, Shah A, Kapatos G, Loeb JA (2012) Layer-specific CREB target gene induction in human neocortical epilepsy. J Neurosci 32(41):14389–14401. doi:10.1523/JNEUROSCI.3408-12.2012
81. Cadet JL, Jayanthi S, McCoy MT, Beauvais G, Cai NS (2010) Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration. CNS Neurol Disord Drug Targets 9(5):526–538
82. Carlezon WA Jr, Duman RS, Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28(8):436–445. doi:10.1016/j.tins.2005.06.005
83. Turgeon SM, Pollack AE, Fink JS (1997) Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res 749(1):120–126
84. Xu W, Kasper LH, Lerach S, Jeevan T, Brindle PK (2007) Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. Embo J 26(12):2890–2903. doi:10.1038/sj.emboj.7601734
85. Alberini CM (2009) Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 89(1):121–145. doi:10.1152/physrev.00017.2008
86. Kandel ER (2012) The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain 5:14. doi:10.1186/1756-6606-5-14
87. Perez-Cadahia B, Drobic B, Davie JR (2011) Activation and function of immediate-early genes in the nervous system. Biochem Cell Biol 89(1):61–73. doi:10.1139/O10-138
88. Kim DJ, Roh S, Kim Y, Yoon SJ, Lee HK, Han CS, Kim YK (2005) High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett 388(2):112–115. doi:10.1016/j.neulet.2005.06.042
89. Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73–82. doi:10.1016/j.neuropharm.2008.06.059
90. Bykhovskaia M (2011) Synapsin regulation of vesicle organization and functional pools. Semin Cell Dev Biol 22(4):387–392. doi:10.1016/j.semcdb.2011.07.003
91. Kwon SE, Chapman ER (2011) Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 70(5):847–854. doi:10.1016/j.neuron.2011.04.001
92. Greengard P, Valtorta F, Czernik AJ, Benfenati F (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259(5096):780–785
93. Kao HT, Porton B, Hilfiker S, Stefani G, Pieribone VA, DeSalle R, Greengard P (1999) Molecular evolution of the synapsin gene family. J Exp Zool 285(4):360–377
94. Fornasiero EF, Bonanomi D, Benfenati F, Valtorta F (2010) The role of synapsins in neuronal development. Cell Mol Life Sci 67(9):1383–1396. doi:10.1007/s00018-009-0227-8
95. Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ, Greengard P (1999) Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 354(1381):269–279. doi:10.1098/rstb.1999.0378
96. Kao HT, Song HJ, Porton B, Ming GL, Hoh J, Abraham M, Czernik AJ, Pieribone VA, Poo MM, Greengard P (2002) A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth. Nat Neurosci 5(5):431–437. doi:10.1038/nn840
97. Hosaka M, Hammer RE, Sudhof TC (1999) A phospho-switch controls the dynamic association of synapsins with synaptic vesicles. Neuron 24(2):377–387
98. Menegon A, Bonanomi D, Albertinazzi C, Lotti F, Ferrari G, Kao HT, Benfenati F, Baldelli P, Valtorta F (2006) Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity. J Neurosci 26(45):11670–11681. doi:10.1523/JNEUROSCI.3321-06.2006
99. Jedynak JP, Uslaner JM, Esteban JA, Robinson TE (2007) Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci 25(3):847–853. doi:10.1111/j.1460-9568.2007.05316.x
100. Rauskolb S, Zagrebelsky M, Dreznjak A, Deogracias R, Matsumoto T, Wiese S, Erne B, Sendtner M, Schaeren-Wiemers N, Korte M, Barde YA (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 30(5):1739–1749. doi:10.1523/JNEUROSCI.5100-09.2010
101. Soulsby M, Bennett AM (2009) Physiological signaling specificity by protein tyrosine phosphatases. Physiology (Bethesda) 24:281–289. doi:10.1152/physiol.00017.2009
102. Caunt CJ, Keyse SM (2013) Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling. Febs J 280(2):489–504. doi:10.1111/j.1742-4658.2012.08716.x
103. Tonks NK (2013) Protein tyrosine phosphatases–from housekeeping enzymes to master regulators of signal transduction. Febs J 280(2):346–378. doi:10.1111/febs.12077
104. Patterson KI, Brummer T, O'Brien PM, Daly RJ (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418(3):475–489
105. Muda M, Manning ER, Orth K, Dixon JE (1999) Identification of the human YVH1 protein-tyrosine phosphatase orthologue reveals a novel zinc binding domain essential for in vivo function. J Biol Chem 274(34):23991–23995
106. Sharda PR, Bonham CA, Mucaki EJ, Butt Z, Vacratsis PO (2009) The dual-specificity phosphatase hYVH1 interacts with Hsp70 and prevents heat-shock-induced cell death. Biochem J 418(2):391–401. doi:10.1042/BJ20081484
107. Bonham CA, Vacratsis PO (2009) Redox regulation of the human dual specificity phosphatase YVH1 through disulfide bond formation. J Biol Chem 284(34):22853–22864. doi:10.1074/jbc.M109.038612
108. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62(1):380–383
109. Mohebiany AN, Nikolaienko RM, Bouyain S, Harroch S (2013) Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack. Febs J 280(2):388–400. doi:10.1111/j.1742-4658.2012.08653.x
110. Fuchs M, Wang H, Ciossek T, Chen Z, Ullrich A (1998) Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development. Mech Dev 70(1–2):91–109
111. Jacobs FM, van der Linden AJ, Wang Y, von Oerthel L, Sul HS, Burbach JP, Smidt MP (2009) Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons. Development 136(14):2363–2373. doi:10.1242/dev.037556
112. Schepens J, Zeeuwen P, Wieringa B, Hendriks W (1992) Identification and typing of members of the protein-tyrosine phosphatase gene family expressed in mouse brain. Mol Biol Rep 16(4):241–248
113. Sommer L, Rao M, Anderson DJ (1997) RPTP delta and the novel protein tyrosine phosphatase RPTP psi are expressed in restricted regions of the developing central nervous system. Dev Dyn 208(1):48–61. doi:10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1
114. Tiran Z, Peretz A, Sines T, Shinder V, Sap J, Attali B, Elson A (2006) Tyrosine phosphatases epsilon and alpha perform specific and overlapping functions in regulation of voltage-gated potassium channels in Schwann cells. Mol Biol Cell 17(10):4330–4342. doi:10.1091/mbc.E06-02-0151
115. Toledano-Katchalski H, Kraut J, Sines T, Granot-Attas S, Shohat G, Gil-Henn H, Yung Y, Elson A (2003) Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases. Mol Cancer Res 1(7):541–550
116. Wang H, Lian Z, Lerch MM, Chen Z, Xie W, Ullrich A (1996) Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. Oncogene 12(12):2555–2562
117. Yan HX, He YQ, Dong H, Zhang P, Zeng JZ, Cao HF, Wu MC, Wang HY (2002) Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and beta-catenin. Biochemistry 41(52):15854–15860
118. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1):9–26. doi:10.1016/j.devcel.2009.06.016
119. Yan HX, Yang W, Zhang R, Chen L, Tang L, Zhai B, Liu SQ, Cao HF, Man XB, Wu HP, Wu MC, Wang HY (2006) Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. J Biol Chem 281(22):15423–15433. doi:10.1074/jbc.M602607200
120. Badde A, Schulte D (2008) A role for receptor protein tyrosine phosphatase lambda in midbrain development. J Neurosci 28(24):6152–6164. doi:10.1523/JNEUROSCI.5593-07.2008
121. Aerne B, Ish-Horowicz D (2004) Receptor tyrosine phosphatase psi is required for Delta/Notch signalling and cyclic gene expression in the presomitic mesoderm. Development 131(14):3391–3399. doi:10.1242/dev.01222
122. Badde A, Bumsted-O'Brien KM, Schulte D (2005) Chick receptor protein tyrosine phosphatase lambda/psi (cRPTPlambda/cRPTPpsi) is dynamically expressed at the midbrain-hindbrain boundary and in the embryonic neural retina. Gene Expr Patterns 5(6):786–791. doi:10.1016/j.modgep.2005.04.002
123. Ben Hamida S, Darcq E, Wang J, Wu S, Phamluong K, Kharazia V, Ron D (2013) Protein tyrosine phosphatase alpha in the dorsomedial striatum promotes excessive ethanol-drinking behaviors. J Neurosci 33(36):14369–14378. doi:10.1523/JNEUROSCI.1954-13.2013
124. McConnell BB, Yang VW (2010) Mammalian Kruppel-like factors in health and diseases. Physiol Rev 90(4):1337–1381. doi:10.1152/physrev.00058.2009
125. Song KD, Kim DJ, Lee JE, Yun CH, Lee WK (2012) KLF10, transforming growth factor-beta-inducible early gene 1, acts as a tumor suppressor. Biochem Biophys Res Commun 419(2):388–394. doi:10.1016/j.bbrc.2012.02.032
126. Cook T, Gebelein B, Belal M, Mesa K, Urrutia R (1999) Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily of Sp1-like zinc finger proteins. J Biol Chem 274(41):29500–29504
127. Zhang JS, Moncrieffe MC, Kaczynski J, Ellenrieder V, Prendergast FG, Urrutia R (2001) A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol Cell Biol 21(15):5041–5049. doi:10.1128/MCB.21.15.5041-5049.2001
128. Kim J, Shin S, Subramaniam M, Bruinsma E, Kim TD, Hawse JR, Spelsberg TC, Janknecht R (2010) Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10. Biochem Biophys Res Commun 401(3):412–416. doi:10.1016/j.bbrc.2010.09.068
129. Upadhyay AK, Cheng X (2011) Dynamics of histone lysine methylation: structures of methyl writers and erasers. Prog Drug Res 67:107–124
130. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6(11):838–849. doi:10.1038/nrm1761
131. Ng SS, Yue WW, Oppermann U, Klose RJ (2009) Dynamic protein methylation in chromatin biology. Cell Mol Life Sci 66(3):407–422. doi:10.1007/s00018-008-8303-z
132. Newton TF, De La Garza R 2nd, Kalechstein AD, Tziortzis D, Jacobsen CA (2009) Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse. Am J Addict 18(4):294–300. doi:10.1080/10550490902925920
133. Shepard JD, Bossert JM, Liu SY, Shaham Y (2004) The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry 55(11):1082–1089. doi:10.1016/j.biopsych.2004.02.032
134. Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y (2011) Neurobiology of the incubation of drug craving. Trends Neurosci 34(8):411–420. doi:10.1016/j.tins.2011.06.001
135. Krasnova IN, Marchant NJ, Ladenheim B, McCoy MT, Panlilio LV, Bossert JM, Shaham Y, Cadet JL (2014) Incubation of methamphetamine and palatable food craving after punishment-induced abstinence. Neuropsychopharmacology. doi:10.1038/npp.2014.50
136. Adachi M, Monteggia LM (2014) Decoding transcriptional repressor complexes in the adult central nervous system. Neuropharmacology 80:45–52. doi:10.1016/j.neuropharm.2013.12.024
137. Kelly RD, Cowley SM (2013) The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts. Biochem Soc Trans 41(3):741–749. doi:10.1042/BST20130010
138. Graff J, Tsai LH (2013) Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci 14(2):97–111. doi:10.1038/nrn3427
139. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243):55–60. doi:10.1038/nature07925
140. Kim MS, Akhtar MW, Adachi M, Mahgoub M, Bassel-Duby R, Kavalali ET, Olson EN, Monteggia LM (2012) An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci 32(32):10879–10886. doi:10.1523/JNEUROSCI.2089-12.2012
141. Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, Attner MA, Cabrera SM, McDonough CB, Brindle PK, Abel T, Wood MA (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 27(23):6128–6140. doi:10.1523/JNEUROSCI.0296-07.2007
142. Itzhak Y, Liddie S, Anderson KL (2013) Sodium butyrate-induced histone acetylation strengthens the expression of cocaine-associated contextual memory. Neurobiol Learn Mem 102:34–42. doi:10.1016/j.nlm.2013.03.007
143. Kennedy PJ, Feng J, Robison AJ, Maze I, Badimon A, Mouzon E, Chaudhury D, Damez-Werno DM, Haggarty SJ, Han MH, Bassel-Duby R, Olson EN, Nestler EJ (2013) Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation. Nat Neurosci 16(4):434–440. doi:10.1038/nn.3354
144. Malvaez M, McQuown SC, Rogge GA, Astarabadi M, Jacques V, Carreiro S, Rusche JR, Wood MA (2013) HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc Natl Acad Sci U S A 110(7):2647–2652. doi:10.1073/pnas.1213364110
145. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM, Wood MA (2010) Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 67(1):36–43. doi:10.1016/j.biopsych.2009.07.032
146. Romieu P, Host L, Gobaille S, Sandner G, Aunis D, Zwiller J (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 28(38):9342–9348. doi:10.1523/JNEUROSCI.0379-08.2008
147. Sanchis-Segura C, Lopez-Atalaya JP, Barco A (2009) Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology 34(13):2642–2654. doi:10.1038/npp.2009.125
148. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N (2009) Translational control of long-lasting synaptic plasticity and memory. Neuron 61(1):10–26. doi:10.1016/j.neuron.2008.10.055
149. Trinh MA, Klann E (2013) Translational control by eIF2alpha kinases in long-lasting synaptic plasticity and long-term memory. Neurobiol Learn Mem 105:93–99. doi:10.1016/j.nlm.2013.04.013
150. Agnihotri NT, Hawkins RD, Kandel ER, Kentros C (2004) The long-term stability of new hippocampal place fields requires new protein synthesis. Proc Natl Acad Sci U S A 101(10):3656–3661. doi:10.1073/pnas.0400385101
151. Kandel ER (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294(5544):1030–1038. doi:10.1126/science.1067020
152. Donnelly N, Gorman AM, Gupta S, Samali A (2013) The eIF2alpha kinases: their structures and functions. Cell Mol Life Sci 70(19):3493–3511. doi:10.1007/s00018-012-1252-6
153. Sachs AB, Sarnow P, Hentze MW (1997) Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 89(6):831–838
154. Lackner DH, Schmidt MW, Wu S, Wolf DA, Bahler J (2012) Regulation of transcriptome, translation, and proteome in response to environmental stress in fission yeast. Genome Biol 13(4):R25. doi:10.1186/gb-2012-13-4-r25
155. Jayanthi S, Deng X, Noailles PA, Ladenheim B, Cadet JL (2004) Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. Faseb J 18(2):238–251. doi:10.1096/fj.03-0295com
156. Jayanthi S, McCoy MT, Beauvais G, Ladenheim B, Gilmore K, Wood W 3rd, Becker K, Cadet JL (2009) Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum. PLoS One 4(6):e6092. doi:10.1371/journal.pone.0006092
157. Jahn H (2013) Memory loss in Alzheimer’s disease. Dialogues Clin Neurosci 15(4):445–454
158. Perl DP (2010) Neuropathology of Alzheimer’s disease. Mt Sinai J Med 77(1):32–42. doi:10.1002/msj.20157
159. Peel AL, Bredesen DE (2003) Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice. Neurobiol Dis 14(1):52–62
160. Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, Perault Pochat MC, Bouras C, Bayer T, Hugon J (2006) Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139(4):1343–1354. doi:10.1016/j.neuroscience.2006.01.047
161. Sadler AJ, Williams BR (2007) Structure and function of the protein kinase R. Curr Top Microbiol Immunol 316:253–292
162. de Haro C, Mendez R, Santoyo J (1996) The eIF-2alpha kinases and the control of protein synthesis. Faseb J 10(12):1378–1387
163. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397(6716):271–274. doi:10.1038/16729
164. Ho YS, Yang X, Lau JC, Hung CH, Wuwongse S, Zhang Q, Wang J, Baum L, So KF, Chang RC (2012) Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: implication in Alzheimer's disease pathogenesis. J Alzheimers Dis 28(4):839–854. doi:10.3233/JAD-2011-111037
165. Ma T, Trinh MA, Wexler AJ, Bourbon C, Gatti E, Pierre P, Cavener DR, Klann E (2013) Suppression of eIF2alpha kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat Neurosci 16(9):1299–1305. doi:10.1038/nn.3486
166. Dmitriev SE, Terenin IM, Andreev DE, Ivanov PA, Dunaevsky JE, Merrick WC, Shatsky IN (2010) GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor. J Biol Chem 285(35):26779–26787. doi:10.1074/jbc.M110.119693
167. Yamada T, Nakao S, Osada S, Imagawa M, Nishihara T (1995) Sequence analysis of the rat jun-D gene. Gene 153(2):285–286
168. Short JD, Pfarr CM (2002) Translational regulation of the JunD messenger RNA. J Biol Chem 277(36):32697–32705. doi:10.1074/jbc.M204553200
169. Hirai SI, Ryseck RP, Mechta F, Bravo R, Yaniv M (1989) Characterization of junD: a new member of the jun proto-oncogene family. Embo J 8(5):1433–1439
170. Ryder K, Lanahan A, Perez-Albuerne E, Nathans D (1989) jun-D: a third member of the jun gene family. Proc Natl Acad Sci U S A 86(5):1500–1503
171. Hernandez JM, Floyd DH, Weilbaecher KN, Green PL, Boris-Lawrie K (2008) Multiple facets of junD gene expression are atypical among AP-1 family members. Oncogene 27(35):4757–4767. doi:10.1038/onc.2008.120
172. Vinson C, Myakishev M, Acharya A, Mir AA, Moll JR, Bonovich M (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol Cell Biol 22(18):6321–6335
173. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4(5):E131–E136. doi:10.1038/ncb0502-e131
174. Wang Y, Cesena TI, Ohnishi Y, Burger-Caplan R, Lam V, Kirchhoff PD, Larsen SD, Larsen MJ, Nestler EJ, Rudenko G (2012) Small molecule screening identifies regulators of the transcription factor DeltaFosB. ACS Chem Neurosci 3(7):546–556. doi:10.1021/cn3000235
175. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072(2–3):129–157
176. Karin M, Liu Z, Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9(2):240–246
177. Hess J, Angel P, Schorpp-Kistner M (2004) AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117(Pt 25):5965–5973. doi:10.1242/jcs.01589
178. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M (1994) Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76(4):747–760
179. Weitzman JB, Fiette L, Matsuo K, Yaniv M (2000) JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell 6(5):1109–1119
180. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouyssegur J, Yaniv M, Mechta-Grigoriou F (2004) JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118(6):781–794. doi:10.1016/j.cell.2004.08.025
181. Hull RP, Srivastava PK, D'Souza Z, Atanur SS, Mechta-Grigoriou F, Game L, Petretto E, Cook HT, Aitman TJ, Behmoaras J (2013) Combined ChIP-Seq and transcriptome analysis identifies AP-1/JunD as a primary regulator of oxidative stress and IL-1beta synthesis in macrophages. BMC Genomics 14:92. doi:10.1186/1471-2164-14-92
182. Smart DE, Vincent KJ, Arthur MJ, Eickelberg O, Castellazzi M, Mann J, Mann DA (2001) JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J Biol Chem 276(26):24414–24421. doi:10.1074/jbc.M101840200
183. Srivastava PK, Hull RP, Behmoaras J, Petretto E, Aitman TJ (2013) JunD/AP1 regulatory network analysis during macrophage activation in a rat model of crescentic glomerulonephritis. BMC Syst Biol 7:93. doi:10.1186/1752-0509-7-93
184. Yoon JK, Lau LF (1994) Involvement of JunD in transcriptional activation of the orphan receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells. Mol Cell Biol 14(12):7731–7743
185. Boss V, Roback JD, Young AN, Roback LJ, Weisenhorn DM, Medina-Flores R, Wainer BH (2001) Nerve growth factor, but not epidermal growth factor, increases Fra-2 expression and alters Fra-2/JunD binding to AP-1 and CREB binding elements in pheochromocytoma (PC12) cells. J Neurosci 21(1):18–26
186. Rosenberger SF, Finch JS, Gupta A, Bowden GT (1999) Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation. J Biol Chem 274(2):1124–1130
187. Lidwell K, Griffiths R (2000) Possible role for the FosB/JunD AP-1 transcription factor complex in glutamate-mediated excitotoxicity in cultured cerebellar granule cells. J Neurosci Res 62(3):427–439
188. Kobierski LA, Chu HM, Tan Y, Comb MJ (1991) cAMP-dependent regulation of proenkephalin by JunD and JunB: positive and negative effects of AP-1 proteins. Proc Natl Acad Sci U S A 88(22):10222–10226
189. Herdegen T, Kovary K, Buhl A, Bravo R, Zimmermann M, Gass P (1995) Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 in the adult rat brain. J Comp Neurol 354(1):39–56. doi:10.1002/cne.903540105
190. Herdegen T, Waetzig V (2001) AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20(19):2424–2437. doi:10.1038/sj.onc.1204387
191. Mellstrom B, Achaval M, Montero D, Naranjo JR, Sassone-Corsi P (1991) Differential expression of the jun family members in rat brain. Oncogene 6(11):1959–1964
192. Mohrmann L, Langenberg K, Krijgsveld J, Kal AJ, Heck AJ, Verrijzer CP (2004) Differential targeting of two distinct SWI/SNF-related Drosophila chromatin-remodeling complexes. Mol Cell Biol 24(8):3077–3088
193. Yan Z, Cui K, Murray DM, Ling C, Xue Y, Gerstein A, Parsons R, Zhao K, Wang W (2005) PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev 19(14):1662–1667. doi:10.1101/gad.1323805
194. Wu JI, Lessard J, Crabtree GR (2009) Understanding the words of chromatin regulation. Cell 136(2):200–206. doi:10.1016/j.cell.2009.01.009
195. Mohrmann L, Verrijzer CP (2005) Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim Biophys Acta 1681(2–3):59–73. doi:10.1016/j.bbaexp.2004.10.005
196. Patsialou A, Wilsker D, Moran E (2005) DNA-binding properties of ARID family proteins. Nucleic Acids Res 33(1):66–80. doi:10.1093/nar/gki145
197. Wilsker D, Probst L, Wain HM, Maltais L, Tucker PW, Moran E (2005) Nomenclature of the ARID family of DNA-binding proteins. Genomics 86(2):242–251. doi:10.1016/j.ygeno.2005.03.013
198. Xu F, Flowers S, Moran E (2012) Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression. J Biol Chem 287(7):5033–5041. doi:10.1074/jbc.M111.279968
199. Racki LR, Narlikar GJ (2008) ATP-dependent chromatin remodeling enzymes: two heads are not better, just different. Curr Opin Genet Dev 18(2):137–144. doi:10.1016/j.gde.2008.01.007
200. Wilsker D, Patsialou A, Dallas PB, Moran E (2002) ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ 13(3):95–106
201. Takeuchi T, Watanabe Y, Takano-Shimizu T, Kondo S (2006) Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev Dyn 235(9):2449–2459. doi:10.1002/dvdy.20851
202. Lai A, Lee JM, Yang WM, DeCaprio JA, Kaelin WG Jr, Seto E, Branton PE (1999) RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol 19(10):6632–6641
203. Yap KL, Zhou MM (2011) Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcription. Biochemistry 50(12):1966–1980. doi:10.1021/bi101885m
204. Huang Y, Fang J, Bedford MT, Zhang Y, Xu RM (2006) Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science 312(5774):748–751. doi:10.1126/science.1125162
205. Chittenden T, Livingston DM, Kaelin WG Jr (1991) The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65(6):1073–1082
206. Defeo-Jones D, Huang PS, Jones RE, Haskell KM, Vuocolo GA, Hanobik MG, Huber HE, Oliff A (1991) Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352(6332):251–254. doi:10.1038/352251a0
207. Manning AL, Dyson NJ (2012) RB: mitotic implications of a tumour suppressor. Nat Rev Cancer 12(3):220–226. doi:10.1038/nrc3216
208. Sahu SC, Swanson KA, Kang RS, Huang K, Brubaker K, Ratcliff K, Radhakrishnan I (2008) Conserved themes in target recognition by the PAH1 and PAH2 domains of the Sin3 transcriptional corepressor. J Mol Biol 375(5):1444–1456. doi:10.1016/j.jmb.2007.11.079
209. Shiio Y, Rose DW, Aur R, Donohoe S, Aebersold R, Eisenman RN (2006) Identification and characterization of SAP25, a novel component of the mSin3 corepressor complex. Mol Cell Biol 26(4):1386–1397. doi:10.1128/MCB.26.4.1386-1397.2006
210. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393(6683):386–389. doi:10.1038/30764
211. Koipally J, Renold A, Kim J, Georgopoulos K (1999) Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. Embo J 18(11):3090–3100. doi:10.1093/emboj/18.11.3090
212. Baine I, Basu S, Ames R, Sellers RS, Macian F (2013) Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. J Immunol 190(3):1008–1016. doi:10.4049/jimmunol.1200792
213. Martin-Ibanez R, Crespo E, Esgleas M, Urban N, Wang B, Waclaw R, Georgopoulos K, Martinez S, Campbell K, Vicario-Abejon C, Alberch J, Chan S, Kastner P, Rubenstein JL, Canals JM (2012) Helios transcription factor expression depends on Gsx2 and Dlx1&2 function in developing striatal matrix neurons. Stem Cells Dev 21(12):2239–2251. doi:10.1089/scd.2011.0607
214. Shah A, Silverstein PS, Singh DP, Kumar A (2012) Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-kappaB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. J Neuroinflammation 9:52. doi:10.1186/1742-2094-9-52